Shares of both Geron (GERN) and Madrigal Pharmaceuticals (MDGL) are soaring after receiving positive news from the Food and Drug Administration.
For Geron, an FDA advisory panel backed its blood disorder treatment. For Madrigal, the FDA approved its treatment for a liver disease known as nonalcoholic steatohepatitis, or NASH.
Yahoo Finance’s Josh Lipton and Julie Hyman discuss the stocks’ reaction in the video above.
For more expert insight and the latest market action, click here to watch this…
Source link
